SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dominik Riss, Martin Burian, Axel Wolf, Veronika Kranebitter, Alexandra Kaider, Christoph Arnoldner, Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial, Head & Neck, 2014, 36, 10
  2. 2
    P. Duffau, E. Lazarro, J.-F. Viallard, Maladie de Rendu-Osler, La Revue de Médecine Interne, 2014, 35, 1, 21

    CrossRef

  3. 3
    Theoni Kanellopoulou, Alexandra Alexopoulou, Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia, Expert Opinion on Biological Therapy, 2013, 13, 9, 1315

    CrossRef